Table 3 Power analysis of the studies
PONV(0–24 h) | PONV (0–6 h) | PONV (6–24 h) | Anti-emetics used (0–24 h) | |
|---|---|---|---|---|
Ashwani K et al. | 10.30 % | NA | NA | 10.30 % |
Gautan B et al. | 5.10 % | 57 % | 45.30 % | 5.50 % |
Mohammad E et al. | 6.90 % | 42.40 % | 64 % | 8.50 % |
Yuksek MS et al. | 24.20 % | 24.20 % | NA | 14.10 % |
D’souza N et al. | 28.70 % | 28.70 % | NA | 23.60 % |
Alghanem SM et al. | 5.20 % | NA | NA | 7.10 % |
Erhan Y et al. | 10.50 % | 20.20 % | 18 % | 6.60 % |
All studies | 12.20 % | 17.90 % | 64 % | 9.10 % |